Know Cancer

or
forgot password

Chalazion Treatment Trial


N/A
18 Years
N/A
Not Enrolling
Both
Eyelid Chalazion

Thank you

Trial Information

Chalazion Treatment Trial

Inclusion Criteria


Inclusion Criteria

- Patients age 18 and above

- Patient with a palpable chalazion on any eyelid

- Patients with multiple chalazia but only single one on each lid

- Normal lid anatomy enabling lid eversion

Exclusion Criteria

- Patients with chalazia with atypical features (recurring chalazion, abnormal
surrounding lid tissue, associated loss of lashed) that may indicate suspicion of
malignancy

- Patients allergic to any agents being used in the study (tobramycin, dexamethasone)

- Patients who have had previous eyelid surgery to the same eyelid as the chalazion

- Patients under 18 years of age

- Patients without palpable lid chalazion

- Patients with multiple chalazia on one eyelid

- Patients with concurrent eyelid infection (cellulitis or conjunctivitis)

- Patients unable to give consent

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Chalazion Size

Outcome Description:

Change of size of eyelid chalazion in mm.

Outcome Time Frame:

4 weeks

Safety Issue:

No

Authority:

Canada: Ethics Review Committee

Study ID:

10-469

NCT ID:

NCT01230593

Start Date:

November 2010

Completion Date:

Related Keywords:

  • Eyelid Chalazion
  • Chalazion

Name

Location